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Abstract Isolated human neutrophils produced no detectable 
( < 10 nM) nitric oxide (NO) before or after activation with 
phorbol 12-myristate 13-acetate (PMA) or a chemotactic 
peptide, TV-formyl-L-methionyl-L-leucyl-L-phenylalanine. Physio-
logical levels of NO (1 nM) added before or after neutrophil 
activation had no effect on their respiratory burst oxygen 
consumption. Neutrophils activated with PMA caused very rapid 
breakdown of exogenously added NO. N O breakdown rates 
recorded at 250 nM NO were 0.09 ± 0.02 and 3.77 ± 0.23 nmol 
NO/min/108 cells (« = 3) before and after activation respectively 
and addition of copper-zinc superoxide dismutase during 
activation significantly decreased this rate (1.06 ±0 .09 nmol 
NO/min/106 cells (« = 3)), suggesting that superoxide (0^~) 
production was mainly responsible for the N O breakdown. These 
results suggest that activation of human neutrophils in vivo will 
dramatically decrease surrounding NO levels, potentially causing 
vasoconstriction, platelet aggregation and adhesion and perox-
ynitrite (ONOO ) formation. 
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1. Introduction 
Neutrophils are by far the most abundant leukocytes 
( > 70%) in the human immune system. It has been well docu-
mented that human neutrophils can be activated by very low 
levels of various stimuli such as phorbol 12-myristate 13-ace-
tate (PMA) [1] or chemotactic peptides such as jV-formyl-L-
methionyl-L-leucyl-L-phenylalanine (FMLP) [2]. During acti-
vation of human neutrophils, cellular oxygen consumption 
increases severalfold [3,4], known as the respiratory burst, 
and results in the production of superoxide radicals (0-7) 
and hydrogen peroxide ( H 2 0 2 ) [5]. 
Recently it has been suggested that during the respiratory 
burst of human neutrophils, nitric oxide (NO) is produced via 
activation of a constitutive nitric oxide synthase (cNOS) [1]. 
However, there are conflicting reports concerning N O produc-
tion in that some studies have not been able to detect any 
N O S activity in human neutrophils, including N O production 
from inducible nitric oxide synthase [6,7]. N O has also been 
reported to inhibit the respiratory burst [8]. Since activated 
neutrophils produce high levels of 0^~, which reacts rapidly 
with N O to give peroxynitrite ( O N O O - ) [9], it is possible that 
activated neutrophils may decrease the ambient level of N O 
rather than increase it. 
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The present work aims to determine: (a) whether human 
neutrophils produce detectable levels of N O , (b) whether N O 
inhibits the respiratory burst, and (c) whether activated neu-
trophils can cause significant levels of N O breakdown. 
2. Materials and methods 
2.1. Preparation of human neutrophils 
Venous blood (18 ml) was drawn from a healthy male volunteer 
and mixed with 2 ml trisodium citrate (3.8%) and 400 al T500 dextran 
(6%). Erythrocytes were allowed to sediment for 45 min and the 
serum (approximately 8 ml) removed. The serum was diluted to 20 
ml with a calcium and magnesium free buffer consisting of: 5.0 mM 
EDTA, 5.6 mM glucose, 10 mM HEPES, 5.4 mM KC1, 137 mM 
NaCl, pH 7.4 (CMF-E). The diluted serum was then centrifuged at 
400 Xg for 5 min. The pellet was resuspended in 10 ml CMF-E and 
layered on a Percoll gradient (6 ml 54% Percoll and 4 ml 78% Percoll) 
and centrifuged at 400Xg for 30 min. 100%> Percoll contained 150 
mM NaCl. Neutrophils were isolated as a distinct band at the 54%> 
Percoll:78% Percoll interface. Neutrophils were washed twice with 
CMF-E to remove Percoll and then stained with either Leishman's 
or Wright's stain. Cell preparations consisted of about 95% of viable 
neutrophils (trypan blue test). Neutrophils were stored at room tem-
perature in an aerated vessel containing CMF-E at approximately 
2X107 cells/ml. 
2.2. Preparation of NO 
NO-saturated water was prepared by purging a gas-tight glass vial 
filled with distilled de-ionised water with nitrogen for approximately 
20 min and then bubbling pure NO gas through the deoxygenated vial 
for a further 15 min or until saturation. The concentration of NO in 
NO-saturated water was taken as 2.0 mM at 20°C [10]. 
2.3. NO and oxygen consumption measurements 
Measurement of NO levels were performed using a Clark-type NO 
electrode (World Precision Instruments) (based on [11]) inserted 
through the top of a Clark-type oxygen electrode, permitting simulta-
neous measurement of NO and oxygen. Both electrodes were con-
nected to a chart recorder. Experiments were performed in a Krebs-
HEPES buffer consisting of: 1.5 mM CaCl2, 5.6 mM glucose, 10 mM 
HEPES, 4.7 mM KC1, 1.2 mM KH 2P0 4 , 1.1 mM MgS04, 118 mM 
NaCl, pH 7.4 at 37°C, stirred continuously at a constant speed. 
Neutrophils (approximately 1 X 106 cells) were activated with either 
PMA (10 ng/ml) or FMLP (4 ug/ml) and the rate of oxygen con-
sumption was calculated before and after the addition of PMA to 
the oxygen electrode vessel chamber and expressed in nmol 02/min/ 
106 cells. 
Aliquots of 1 uM NO were added by injecting an aliquot of NO-
saturated water (see above) into the incubation chamber in triplicate 
before and after neutrophil stimulation by PMA or FMLP and also 
after Cu/Zn-SOD (10 |ig/ml) addition. NO breakdown rate was calcu-
lated in units of nmol NO/min. The effect of a steady-state level of 
1 aM NO for 10 min (achieved by adding small aliquots of NO to the 
incubation chamber - measured by the NO electrode) before neutro-
phil activation on respiratory burst oxygen consumption was also 
tested. 
2.4. Materials 
Percoll and T500 dextran were purchased from Pharmacia. NO 
gas was from MG Gas Products. Cu/Zn-SOD was from bovine 
kidney, suspended in 3.8 M ( N H ^ S Q i , pH 7.0 and bought from 
Sigma Chemical Co. All other chemicals were from Sigma Chemical 
Co. 
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Fig. 1. Activated human neutrophils cause rapid NO breakdown. Neutrophils (approximately 1x10s cells/ml) were incubated with an oxygen 
electrode (upper trace) and NO electrode (lower trace) to simultaneously measure oxygen and NO levels. Aliquots of 1 uM NO were added fol-
lowed by 10 ng/ml PMA, followed by three aliquots of 1 pM NO, followed by 10 ug/ml Cu/Zn-SOD, followed by another three 1 p,M NO ali-
quots. NO breakdown (lower trace) is greatly increased by PMA (10 ng/ml) addition to neutrophils and this fast rate is decreased by the pres-
ence of Cu/Zn-SOD (10 ng/ml). PMA also causes an increase in the oxygen consumption (upper trace) of neutrophils (known as the 
respiratory burst). Experiments were performed using approximately 106 cells/ml in Krebs-HEPES medium, pH 7.4 at 37°C. 
3. Results 
3.1. NO production by neutrophils 
NO was not detected before or after PMA (1-10 ng/ml) 
stimulation of neutrophils (1-2 X 106 cells) in the presence of 
5 mM L-arginine. Cu/Zn-SOD (10 |ig/ml) was also added to 
activated neutrophils to reduce the number of free 0^ ~ radi-
cals, and also 0.1 uM catalase in order to break down any 
H2O2 produced, but no NO production was detected. Neu-
trophils were also treated with a calcium ionophore, A23187 
(0.1-1 uM), in order to increase intracellular calcium levels. 
A23187 addition before or after neutrophil activation with 
PMA did not cause measurable NO production. Also, 
A23187 had no effect on the oxygen consumption of neutro-
phils before or after activation. Staurosporine (10-100 nM), a 
protein kinase inhibitor, was also added to neutrophils before 
or after activation. Protein kinases can cause inhibition of 
NOS by phosphorylation however including staurosporine 
did not permit measurable NO production. NO production 
was not detected either when FMLP (4 ng/ml) was used to 
activate neutrophils. 
3.2. Neutrophil oxygen consumption and the effect of NO on 
the neutrophil respiratory burst 
PMA (10 ng/ml) was found to increase oxygen consump-
tion of human neutrophils (approximately 1 X 106 cells) from 
a basal level of 1.35 ±0.01 nmol O2/min/10
6 cells to 
6.80 ± 0.36 nmol 02/min/lO6 cells (n = 6). The increase in oxy-
gen consumption was observed within the response time of the 
oxygen electrode (about 5 s) (Fig. 1). PMA (1 ng/ml) did not 
cause a measurable increase in oxygen consumption (result 
not shown). In order to investigate whether NO inhibits the 
respiratory burst, NO was added either before or during the 
burst, and the oxygen consumption rate measured during the 
burst. Prior to activation of the neutrophils, the NO level in 
the reaction medium was maintained at close to 1 pM NO for 
10 min by adding aliquots of NO to the vessel (similar to Fig. 
1). A steady-state level of 1 uM NO for 10 min prior to 
activation did not affect the oxygen consumption during the 
respiratory burst of neutrophils (approximately 1 X 106 cells) 
activated with PMA (10 ng/ml). Respiratory burst oxygen 
consumption rates were 6.88 ±0.36 nmol 02/min/lO6 cells 
after treatment of neutrophils with 1 uM NO for 10 min 
Table 1 
Rate of NO decay before neutrophil activation with PMA (10 ng/ml) and after activation and also in the presence of Cu/Zn-SOD (10 |J,g/ml) 
NO decay rate at 250 nM NO S.D. n 
(nmol NO/min/106 cells) 
Before PMA addition 
After PMA addition 
After PMA and SOD addition 
0.09 
3.77 
1.06 
0.02 
0.23 
0.09 
Experiments were performed using approximately 1X106 cells/ml in Krebs-HEPES medium, pH 7.4 at 37°C. Results expressed as mean ± S.D. 
where n = number of experiments. 
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and 6.74 ±0.44 nmol CVmin/lO6 cells for control neutrophils 
(«= 3). Also, addition of up to five 1 uM aliquots of NO 
during the respiratory burst had no effect on the oxygen con-
sumption rate of activated neutrophils (Fig. 1). 
3.3. NO breakdown by neutrophils 
We tested whether neutrophils could cause a significant rate 
of NO breakdown, either before or after activation, by adding 
an aliquot of NO to the medium and following its rate of 
breakdown with the NO electrode. Prior to activation, neu-
trophils did not significantly increase the rate of NO break-
down compared to medium alone. Activated human neutro-
phils caused rapid breakdown of exogenously added NO (Fig. 
1). Rapid NO decay was observed immediately after adding 
PMA (10 ng/ml) or FMLP (4 itg/ml) to neutrophils. All NO 
additions were made at approximately 150-200 uM O2. The 
decay rate of NO added before and after neutrophil stimula-
tion by PMA and also after Cu/Zn-SOD (10 itg/ml) addition 
was calculated at a level of 250 nM NO and expressed in 
terms of nmol NO/min/ml (Table 1). Cu/Zn-SOD (10 ng/ml) 
decreased the NO breakdown rate during the respiratory burst 
of neutrophils. PMA itself (in the absence of neutrophils) did 
not affect the breakdown rate of added NO. When FMLP (4 
Hg/ml) was used instead of PMA as an activator of the respi-
ratory burst, it caused a similar increase in the rate of NO 
breakdown by neutrophils (result not shown). NO reacts with 
0;T to yield ONOO" [9] and ONOO" is known to react with 
other biomolecules to generate NO donors [12]. However, this 
reaction is likely to be slow and delayed and because of the 
high levels of 0^ ~ produced by activated neutrophils, it is 
unlikely that we would have detected any secondary NO pro-
duction. 
4. Discussion 
NO production from macrophages is well documented (re-
viewed in [13]) and has recently been reported in human mac-
rophages [14,15]. However, production of NO from neutro-
phils, the main leukocyte type and certainly the major cell 
type at early stages of inflammation, is less clearly understood. 
Certainly inducible NOS (i-NOS) activity has been observed 
in rodent neutrophils by activating the cells with various 
agents such as interferon-y, tumour necrosis factor a and lip-
opolysaccharide [16,17]. NO production from i-NOS in hu-
man neutrophils is generally unclear, although recently it 
has been demonstrated in neutrophils from the human urinary 
tract [18]. Some studies have failed to show any NO produc-
tion even after cytokine treatment of human neutrophils [6,7]. 
Yet recently, it has been reported that NO production from 
cNOS was detected during the respiratory burst of human 
neutrophils activated with PMA [1]. At saturating PMA con-
centrations, NO production was 0.56 ±0.04 nmol/min/106 
cells, measured by the oxidation of oxymyoglobin to metmyo-
globin. 
In the present work, we were unable to detect measurable 
levels of NO from human neutrophils, before or after activa-
tion with PMA. We used an NO electrode for NO assay, 
which can detect NO levels above about 10 nM. Half-maximal 
NO production was observed in [1] at about 1 ng PMA/ml; 
however, we did not observe any NO over the range 1-10 ng 
PMA/ml. NO was not measurable even in the presence of Cu/ 
Zn-SOD and low levels of catalase; these were included be-
cause it has also been shown that 0^ ~ and H2O2 are produced 
during the respiratory burst of human neutrophils [5,19]. 
However, it remains possible that we did not detect NO 
with the electrode in the presence of PMA because the rate 
of NO breakdown is so high, even in the presence of SOD. 
Thus we tried to stimulate cNOS in the absence of PMA 
activation, by adding the calcium ionophore A23187 and the 
protein kinase inhibitor staurosporine, both of which have 
been reported to stimulate cNOS activity in cells [20]. How-
ever, neither agent caused detectable NO release, thus if hu-
man neutrophils do produce NO, the rate must be low. 
Recent work indicates that NO reversibly inhibits the res-
piratory burst of PMA-activated neutrophils [8], so we tested 
the effect of a sustained level of 1 uM NO for 10 min on the 
respiratory burst of human neutrophils. This treatment had 
no effect on the neutrophil respiratory burst. In [8], neutro-
phils were treated with high micromolar aliquots of NO. 
These levels of NO will not exist for more than a fraction 
of a second because in an oxygenated medium, the NO will 
rapidly react with oxygen to give NO2 and N2O3 [21] and 
these strongly oxidising species might have been responsible 
for the inhibition observed in [8]. We used a level of NO (1 
uM) which is at the top end of the physiological or patholog-
ical range, but which does not give rise to significant levels of 
NO2 or N2O3. We did not see any inhibition of the respira-
tory burst under these conditions and we conclude that such 
inhibition is unlikely to occur in vivo. 
We found that neutrophils activated with PMA cause very 
rapid breakdown of exogenously added NO. The fact that Cu/ 
Zn-SOD caused a large decrease in the NO breakdown rate 
by activated neutrophils suggests that NO rapidly reacts with 
O^ radicals produced during activation. If all the extra oxy-
gen consumption during activation (5.45 nmol O2/min/10
6 
cells) was used to produce O^", this rate would be sufficient 
to quantitatively account for the activated rate of NO break-
down (3.77 nmol NO/min/106 cells). 
If neutrophils do not produce significant levels of NO, but 
rather activated neutrophils cause rapid breakdown of exo-
genous NO, then activation of neutrophils in vivo may sig-
nificantly decrease tissue NO levels. This decrease in NO levels 
would promote vasoconstriction and platelet aggregation and 
adhesion, and inhibit inflammation. This regulatory role 
might be a significant physiological function of the respiratory 
burst O^ production. During inflammation, high levels of 
activated neutrophils enter the inflamed tissue, due to local 
vasodilation and increased endothelial permeability, caused in 
part by increased NO production [22]. The increased NO 
breakdown due to the presence of activated neutrophils might 
function as a feedback to inhibit further inflammation. The 
production of ONOO - accompanying NO breakdown might 
contribute to the cytotoxicity of neutrophils [1]. 
In conclusion, the present study indicates that activated 
human neutrophils cause rapid breakdown of added NO, 
probably via the reaction of NO with Oj" produced during 
the respiratory burst. This suggests the possibility that human 
neutrophil activation might significantly decrease in vivo NO 
levels and thus might regulate vasodilation, inflammation and 
other NO-regulated functions. 
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